The FDA has authorized the use of Tekmira Pharmaceuticals’ (NASDAQ:TKMR; TSX:TKM) TKM-Ebola therapy under expanded access and compassionate use protocols to treat Ebola virus infected individuals.
Trending
- Four dead, 70 vehicles burnt in fuel tanker explosion in Rivers – Police
- Navy recruits 1,486 to tackle oil theft, piracy – Minister
- Ondo 2024: Sowore’s party’s candidate emerges
- LG poll: OYSIEC apologises for lateness, speaks on alternative to voter card
- Breaking: Olukoyede restructures EFCC, appoints CoS, Zonal Directors
- 19 children feared killed by measles complications in Adamawa
- NCoS speaks on reported one-bedroom flat for Bobrisky
- Gombe LG polls: Ruling party sweeps all positions
